|
P.A. Vorobyev, L.Yu. Bezmenitsina
Epidemiology and quality of life in patients with chronic renal failire and anemia, receiving programm hemodyalisis. Part 2. Quality of life and costs of erythropoietin treatment
|
№2 / 2011
|
|
N.Yu. Borovkova, N.N. Borovkov, Yu.A. Khor'kina, T.I. Maslova, T.B. Pakhomova
Patient training as an approach to enhansing of treatment compliance in renal arterial hypertension
|
№2 / 2011
|
|
О.V. Rtyscheva, O.F. Kalev
Structural remodeling of myocardium in patients with arterial hypertension, receiving chronic haemodyalisis
|
№2 / 2011
|
|
Yu.S. Milovanov, L.Yu. Milovanov, L.V. Kozlovskaya
Use of trihydric iron preparations in treatment of anemia in patients with pre-dialysis renal failure
|
№2 / 2011
|
|
Yu.A. Vialkina, S.V. Shalaev
Creatinine clearance in long-term prognosis of risk of cardiovascular death in patients with acute coronary syndrome without ST segment elevation
|
№2 / 2011
|
|
A.Yu. Zemchenkov, K.A.Vishnevsky, R.P.Gerasimchuk, S.L.Gavric, T.G.Kostyleva, V.N.Suchkov
The efficacy and safety evaluation of the domestic erythropoietin-β. The review and open multicenter study report
|
№2 / 2011
|
|
E.V. Shutov, S.V. Lashutin, I.G. Kolomiitseva, E.V. Shuvalov
Treatment of anemia with methoxypolyethyleneglycol – epoetin beta in patients on haemodyalisis
|
№2 / 2011
|
|
Nephropathy in heroin and cocaine abusers
|
№2 / 2011
|
|
I.E. Tareeva
Variants of the lupous nephritis course
|
№2 / 2011
|
|
E.V. Voloshinova, O.S. Lobanova, N.M. Nikitin
Systemic amyloidosis in patient with gout
|
№1 / 2011
|
|
R.Kh. Galeev, D.D. Khamitov
The current state of problem of kidney tumors and analysis of rational approaches to medical interventions
|
№1 / 2011
|
|
V.V. Fomin
Isolated systolic hypertension: global risk factor
|
№1 / 2011
|
Русский
